Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti--Synuclein Monoclonal Antibody, in Patients with Parkinson Disease: A Randomized Clinical Trial

Joseph Jankovic, Ira Goodman, Beth Safirstein, Tonya K. Marmon, Dale B. Schenk, Martin Koller, Wagner Zago, Daniel K. Ness, Sue G. Griffith, Michael Grundman, Jay Soto, Susanne Ostrowitzki, Frank G. Boess, Meret Martin-Facklam, Joseph F. Quinn, Stuart H. Isaacson, Omid Omidvar, Aaron Ellenbogen, Gene G. Kinney

Research output: Contribution to journalArticlepeer-review

119 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti--Synuclein Monoclonal Antibody, in Patients with Parkinson Disease: A Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences